George C. Clark, VP, Chief Accounting Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 4,200 shares at $141.50 ($594K) on 2022-05-10, disclosed to the SEC on 2022-05-12.
Open-market sale of $594k BHVN by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BHVN | SELL | 2021-12-22 | $474K | — | Filing → |